Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07345715

Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy

Comparison Between Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy: A Prospective, Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
3 Years – 7 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the efficacy of using oral Melatonin versus nebulized Dexmedetomidine in limitation of emergence agitation in children undergoing adenotonsillectomy.

Detailed description

Adenotonsillectomy is one of the most commonly performed surgical procedures in children with high incidence of emergence agitation about 80% and high degree of post operative pain. Oral midazolam, a short-acting benzodiazepine, is commonly used as a standard premedication in children due to its well-established anxiolytic, sedative, and amnestic effects. It works by enhancing GABAergic neurotransmission in the central nervous system, helping reduce anxiety and facilitating a smoother anesthetic induction and emergence. Dexmedetomidine is a centrally acting α-2 adrenergic agonist with sedative, hypnotic, analgesic, anxiolytic, anti-sialagogue, antinociceptive and sympatholytic action.

Conditions

Interventions

TypeNameDescription
DRUGNormal salineParticipants will receive placebo nebulizer (3 ml of normal saline) without drug and 0.5 mg/kg of midazolam dissolved in Apple Juice.
DRUGOral melatonin syrupParticipants will receive placebo nebulizer (3 ml of normal saline) without drug and 0.2 mg/kg of oral melatonin syrup.
DRUGNebulized dexmedetomidineParticipants will receive placebo syrup (Apple Juice) and 2 µ/kg nebulized dexmedetomidine prepared in 0.9% normal saline to a final volume of 3ml.

Timeline

Start date
2025-07-01
Primary completion
2027-07-01
Completion
2027-07-01
First posted
2026-01-16
Last updated
2026-01-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07345715. Inclusion in this directory is not an endorsement.